Hydrus Microstent for Refractory Open-Angle Glaucoma

Clinical Trial Description

Participants will attend a screening visit, a baseline visit, a surgery visit, and 8 post-operative visits (Day 1, Day 7, Month 1, Month 2, Month 3, Month 6, Month 9, Month 12), for a total individual duration of approximately 14 months. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT01157364` - Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension	Phase 1/Phase 2
Completed	`NCT02558374` - Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension	Phase 3
Completed	`NCT01456390` - Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents	N/A
Completed	`NCT01415401` - Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada	Phase 4
Completed	`NCT01487655` - Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients	N/A
Completed	`NCT01340014` - Patient Preference Comparison of AZARGA Versus COSOPT	Phase 4
Completed	`NCT01444040` - Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost	Phase 4
Completed	`NCT01426867` - A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%	Phase 2
Completed	`NCT01455467` - Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery	N/A
Completed	`NCT01444105` - Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty	N/A
Completed	`NCT01443988` - Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost	Phase 4
Completed	`NCT00759239` - Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension	Phase 4
Completed	`NCT00397241` - 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations	Phase 4
Completed	`NCT00273481` - Cosopt Versus Xalacom	Phase 4
Completed	`NCT00918346` - Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation	Phase 3
Completed	`NCT00716742` - Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)	N/A
Completed	`NCT02558400` - Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension	Phase 3
Withdrawn	`NCT03648229` - African Glaucoma Laser Trial	Phase 4
Completed	`NCT01978600` - Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension	Phase 4
Completed	`NCT01699464` - A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months	Phase 2

NCT number	NCT03267134
Study type	Interventional
Source	Ivantis, Inc.
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2017
Completion date	December 16, 2022

Hydrus Microstent for Refractory Open-Angle Glaucoma — SUMMIT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms